A retrospective study evaluating the effectiveness of therapeutic guidance for lifestyle-related diseases.

A retrospective study evaluating the effectiveness of therapeutic guidance for lifestyle-related diseases. - A retrospective study evaluating the effectiveness of therapeutic guidance for lifestyle-related diseases.

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000058914

Enrollment

Registered

2025-08-28

Start date

2025-11-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Any of the following: diabetes, hypertension, or dyslipidemia

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: All data collected at our institution between June 1, 2024, and May 31, 2025.

Exclusion criteria

Exclusion criteria: Individuals who requested to be excluded from the study through the opt-out process regarding the study's s purpose and content

Design outcomes

Primary

Measure	Time frame
Changes in the following parameters before and after therapeutic guidance among all participants: body weight, BMI, blood pressure (systolic and diastolic), HbA1c, total cholesterol, triglycerides, HDL cholesterol, and LDL cholesterol."	—

Secondary

Measure	Time frame
Changes in the following parameters before and after therapeutic guidance, stratified by patient group: HbA1c, body weight, and BMI in patients with diabetes; blood pressure in patients with hypertension; and body weight, BMI, total cholesterol, triglycerides, HDL cholesterol, and LDL cholesterol in patients with dyslipidemia. Additionally, changes in responses to lifestyle survey items compared to pre-guidance levels.	—

Measure

Time frame

Changes in the following parameters before and after therapeutic guidance, stratified by patient group: HbA1c, body weight, and BMI in patients with diabetes; blood pressure in patients with hypertension; and body weight, BMI, total cholesterol, triglycerides, HDL cholesterol, and LDL cholesterol in patients with dyslipidemia. Additionally, changes in responses to lifestyle survey items compared to pre-guidance levels.

—

Countries

Japan

Contacts

Public ContactSusumu Kimura

Kimura Naika Clinic N/A

kimuranaika_clinic_kyoto@yahoo.co.jp0772-43-2134

Outcome results